LaCAR MDx Technologies S.A.

LaCAR MDx Technologies is a Belgian company specialising in the development of IVDR, ISO 13485 and MDSAP-certified automated in vitro diagnostic solutions. Active in more than 50 countries, it offers innovative tests for neonatal screening and pharmacogenetics, in particular using non-DNA extraction technologies.

LaCAR offers complete ‘from sample to result’ solutions, adapted to all laboratory formats, from the smallest hospital site to large-scale screening platforms. In 2025, LaCAR strengthened its leadership with the acquisition of the Newborn Screening division of Baebies, Inc, incorporating SEEKER technology for the screening of lysosomal diseases.